Compare AbCellera Biologics Inc (ABCL) vs Core and Main Inc (CNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Core and Main Inc — how do they compare? AbCellera Biologics Inc trades at $9.03 (market cap $2.99B), while Core and Main Inc trades at $46.73 (market cap $8.73B). The key difference: Core and Main Inc is far larger — about 2.9× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Core and Main Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | CNM | |
|---|---|---|
Market Cap | $2.99B | $8.73B |
Sector | Health | Technology |
52-Week High | $9.76 | $66.98 |
52-Week Low | $2.78 | $42.37 |
Enterprise Value | $2.58B | $11.02B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Core and Main Inc
Core & Main is a leading US distributor of water, wastewater, storm drainage, and fire protection products. It provides essential infrastructure solutions to municipalities, private water companies, and contractors.
Read more on CNM →
